awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38375767-BDA38940-888C-4DD8-8C90-A8C84BC07445
Q38375767-BDA38940-888C-4DD8-8C90-A8C84BC07445
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38375767-BDA38940-888C-4DD8-8C90-A8C84BC07445
Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis.
P2860
Q38375767-BDA38940-888C-4DD8-8C90-A8C84BC07445
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38375767-BDA38940-888C-4DD8-8C90-A8C84BC07445
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80c146476b1b5d08852dd19aae15e8f8c2c0f9a0
P2860
Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open-label extension analysis